ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
86,514.46
-0.27%
S&P 500
5,770.20
0.55%
Dow Jones
42,801.72
0.52%
US Dollar vs Yen
148.045
0.02%
Brent Oil
70.235
0.00%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ

  6. TransCode Therapeutics Inc (RNAZ) 銘柄情報

TransCode Therapeutics Inc

TransCode Therapeutics Inc (RNAZ)

NASDAQ
1.57
-0.12
(-7.10%)
終了 3月8日 6:00AM
15分遅延
1.60
0.03
(1.91%)
取引時間後: 9:59AM
15分遅延

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

主要統計と詳細

通貨
1.60
買値
1.52
売値
4.50
出来高
928,586
1.51 日の範囲 1.65
1.55 52 週間の範囲 66.33
時価総額
1.114M
前日終値
1.69
始値
1.65
時刻
300
@
1.6
(formt)
最終取引時間
財務取引量
US$ 1,474,615
VWAP
1.588
平均取引量 (3 か月)
1,811,403
発行済株式数
696,233
配当利回り
-
PER
-0.06
1 株当たり利益 (EPS)
-26.64
歳入
-
純利益
-18.55M

TransCode Therapeutics Inc について

TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic cancer, which has the potential to produce regre... TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic cancer, which has the potential to produce regression without recurrence in a range of cancers, including breast, pancreatic, ovarian and colon cancer, glioblastomas and others. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
www.transcodetherapeutics.com
本社
Wilmington, Delaware, USA
設立
-
TransCode Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker RNAZ. The last closing price for TransCode Therapeutics was US$1.69. Over the last year, TransCode Therapeutics shares have traded in a share price range of US$ 1.55 to US$ 66.33.

TransCode Therapeutics currently has 696,233 shares in issue. The market capitalisation of TransCode Therapeutics is US$1.18 million. TransCode Therapeutics has a price to earnings ratio (PE ratio) of -0.06.

RNAZ 最新ニュース

その他のニュース

Form 8-K - Current report
Edgar (US Regulatory)
2025年2月26日
RNAZ (-7.10%)

Form 8-K - Current report
Edgar (US Regulatory)
2025年2月5日
RNAZ (-7.10%)

Form DEF 14A - Other definitive proxy statements
Edgar (US Regulatory)
2024年12月31日
RNAZ (-7.10%)

Form 8-K - Current report
Edgar (US Regulatory)
2024年12月21日
RNAZ (-7.10%)
期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.9-362.52.541.5511397551.85786914CS
4-9.66-85.790408525811.2612.771.555608354.08046648CS
12-5.65-77.93103448287.2516.731.5518114038.64651864CS
26-6.9536-81.29442573898.553626.41.55155660212.56988535CS
52-21.632-93.112947658423.23266.331.55137247717.39038635CS
156-59398.4-99.997306397359400813121.5516322716212.12089129CS
260-158398.4-99.9989898991584001848001.55166760226206.5677241CS

RNAZ - Frequently Asked Questions (FAQ)

What is the current TransCode Therapeutics share price?
The current share price of TransCode Therapeutics is US$ 1.60
How many TransCode Therapeutics shares are in issue?
TransCode Therapeutics has 696,233 shares in issue
What is the market cap of TransCode Therapeutics?
The market capitalisation of TransCode Therapeutics is USD 1.18M
What is the 1 year trading range for TransCode Therapeutics share price?
TransCode Therapeutics has traded in the range of US$ 1.55 to US$ 66.33 during the past year
What is the PE ratio of TransCode Therapeutics?
The price to earnings ratio of TransCode Therapeutics is -0.06
What is the reporting currency for TransCode Therapeutics?
TransCode Therapeutics reports financial results in USD
What is the latest annual profit for TransCode Therapeutics?
The latest annual profit of TransCode Therapeutics is USD -18.55M
What is the registered address of TransCode Therapeutics?
The registered address for TransCode Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the TransCode Therapeutics website address?
The website address for TransCode Therapeutics is www.transcodetherapeutics.com
Which industry sector does TransCode Therapeutics operate in?
TransCode Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
CAPSCapstone Holding Corp
US$ 3.50
(1,300.00%)
36.33k
ABLVAble View Global Inc
US$ 1.73
(137.18%)
5.13M
SUNESUNation Energy Inc
US$ 0.402999
(127.55%)
476.73M
BTOGBit Origin Ltd
US$ 0.6117
(118.46%)
618.03M
DWTXDogwood Therapeutics Inc
US$ 6.63
(49.66%)
25.77M
ALBTAvalon GloboCare Corporation
US$ 6.96
(-36.15%)
577.55k
SCNXScienture Holdings Inc
US$ 1.55
(-35.68%)
1.59M
ACXPAcurx Pharmaceuticals Inc
US$ 0.4572
(-29.88%)
1.18M
RETOReTo Eco Solutions Inc
US$ 5.42
(-27.73%)
108.27k
OCTOEightco Holdings Inc
US$ 1.08
(-27.03%)
336.99k
BTOGBit Origin Ltd
US$ 0.6117
(118.46%)
622.67M
SUNESUNation Energy Inc
US$ 0.402999
(127.55%)
482.05M
NVDANVIDIA Corporation
US$ 112.69
(1.92%)
341.94M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 10.675
(-0.70%)
143.04M
ICONIcon Energy Corporation
US$ 0.169898
(17.17%)
142.23M

RNAZ Discussion

投稿を表示

最近閲覧した銘柄

NASDAQ
RNAZ
TransCode Therapeutics
BIT
BEST
Be Shaping the Future
BIT
UC1C56
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2025 ADVFN PLC - 全著作権所有

広告を削除する

サインアップして広告なしのエクスペリエンスを体験してください

広告なし

今すぐ試してください

広告を残す